Skip to content

Hemodynamics and Cutaneous Microcirculation during the Induction of General Anesthesia With and Without Esketamine

Hemodynamics and Cutaneous Microcirculation during the Induction of General Anesthesia With and Without Esketamine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022440
Enrollment
40
Registered
2020-12-28
Start date
2019-05-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I95.2 I97.9 T88.5

Interventions

Group 1: Induction of general anesthesia with sufentanil, propofol and rocuronium in adult patients prior to elective abdominal or thoracic surgery. Group 2: Induction of general anesthesia with sufen

Sponsors

Klinik für Anästhesiologie und IntensivtherapieUniversitätsklinikum Carl Gustav Carus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Medical necessity of invasive blood pressure monitoring (i.e. inserting arterial line) prior to the induction of general anesthesia.

Exclusion criteria

Exclusion criteria: - age 120 kg - ASA score > 4 - emergency operation - hemodynamic instability requiring medical intervention prior to induction (vasopressors, inotropes etc.) - cerebrovascular disease - known carotid stenosis - LVEF 2,25 mg/dl or need for chronic dialysis - liver cirrhosis CHILD B oder C - ACS = 3 months prior - acute hematological malignancy (acute leukemias, lymphomas) - ongoing chemotherapy - history of Raynaud's syndrome - systemic sclerosis - systemic vasculitides - peripheral artery disease additional exclusion criteria for patients receiving esketamine: - hyperthyroidism - ACS = 12 months prior - PCI or CABG = 12 months prior - hydrocephalus - schizophrenia - depression - substance use disorders - bipolar disorder - blood pressure > 190 mmHg systolic upon arrival in the holding bay

Design outcomes

Primary

MeasureTime frame
Effects of the addition of esketamine to a standardized induction protocol on cutaneous microcirculation (via laser doppler flowmetry, distal-proximal gradient and capillary refilling time).

Secondary

MeasureTime frame
Effekts of the addition of esketamine to a standardized induction protocol on cardiac output (via pulse contour analysis), mean arterial blood pressure and necessary dose of noradrenaline per kilogram of body weight to maintain normal blood pressure.

Countries

Germany

Contacts

Public ContactClaudia Apel

Klinik für Anästhesiologie und Intensivtherapie Universitätsklinikum Dresden

Claudia.Apel@uniklinikum-dresden.de+49 351 4584110

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026